Moreover, based on our transcriptomic analysis of the very few cells surviving perhexiline treatment, this population could potentially be eliminated using aldose reductase inhibitors, some of which have successfully been used to reverse drug resistance in prostate and colorectal cancer lines.[53]. Here, AKR1B1 is linked to colorectal cancer.